Medical technology company Abanza has received FDA 510(k) clearance for QuadLock, a fixation system for ACL reconstruction.
The system can be used across several graft configurations that are commonly used in ACL procedures, such as quadriceps tendon, quadrupled semitendinosus/gracilis, and bone–patellar tendon–bone, according to a Jan. 27 news release from Abanza.
The knotless, bidirectional tension-adjustable fixation system displayed a 500% reduction in cyclic displacement compared to conventional fixation methods during biomechanical testing.
There are about 300,000 ACL reconstruction surgeries performed in the U.S. each year, the release said.
